The Air Liquide Healthcare subsidiary has appointed Virginie Cavalli as Chief Executive Officer, effective September 1, 2026.
Seppic designs, manufactures, and distributes a wide range of specialty ingredients used in cosmetics, nutraceuticals, pharmaceuticals, veterinary products, and industrial applications. Nearly 900 employees support customers in 100 countries through the company’s subsidiaries and distributor network.
A graduate of EM Lyon Business School with a degree in financial strategy, Virginie Cavalli joined the Air Liquide Group in 1992. Over the past three decades, she has held a range of functional and leadership roles across multiple business units and international markets, including France, the United States, Chile, and Singapore. Most recently, she served as CEO of Air Liquide Japan before becoming Deputy Group Vice President of Human Resources in 2023.
At the helm of Seppic, Virginie Cavalli “a solid expertise in business development and operational and financial management, as well as an international strategic vision, which will support the company’s ambitions for the coming years.”
